Cyclin-dependent kinase-5 (Cdk5) increases amyloid beta levels through FOXO3 activity and induces the pathogenesis of Alzheimer’s disease [51]. The gene discussed is FOXO3; the disease is early-onset autosomal dominant Alzheimer disease.